SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-006758
Filing Date
2021-03-22
Accepted
2021-03-22 16:30:45
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cbli20201231_10k.htm 10-K 1504431
2 EXHIBIT 21.1 ex_221829.htm EX-21.1 4115
3 EXHIBIT 23.1 ex_221830.htm EX-23.1 3593
4 EXHIBIT 31.1 ex_221831.htm EX-31.1 11841
5 EXHIBIT 32.1 ex_221832.htm EX-32.1 9496
12 cbli01.jpg GRAPHIC 65935
13 ex_168660img001.jpg GRAPHIC 4918
14 ex_168660img002.jpg GRAPHIC 6643
15 letterhead.jpg GRAPHIC 4097
  Complete submission text file 0001437749-21-006758.txt   5539977

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbli-20201231.xml EX-101.INS 882832
7 XBRL TAXONOMY EXTENSION SCHEMA cbli-20201231.xsd EX-101.SCH 51149
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20201231_cal.xml EX-101.CAL 38481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20201231_def.xml EX-101.DEF 362116
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20201231_lab.xml EX-101.LAB 337619
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20201231_pre.xml EX-101.PRE 390782
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32954 | Film No.: 21761679
SIC: 2834 Pharmaceutical Preparations